<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="119478">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02087670</url>
  </required_header>
  <id_info>
    <org_study_id>GrupoRS0002</org_study_id>
    <nct_id>NCT02087670</nct_id>
  </id_info>
  <brief_title>Natriuretic Brain Pro-peptid Changes in Patients With Chronic Heart Failure Within a Cardiac Rehabilitation Program</brief_title>
  <official_title>Natriuretic Brain Pro-peptid (Pro-BNP)Changes in Patients With Chronic Heart Failure Enroled in a Controlled, Supervised Exercise Protocol Within a Cardiac Rehabilitation Program</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Grupo Rehabilitacion en Salud</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Clinica Las Americas</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Grupo Rehabilitacion en Salud</source>
  <oversight_info>
    <authority>Colombia: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluate pro-BNP levels, oxygen consumption, functional class, and quality of life in
      patients with chronic heart failure after participating in an exercise program  and compare
      them baseline and 2 months, with another group who underwent an educational program.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Clinical controlled trial with a double blinded with a aleatory number sequence as the
      randomization method, patients will be assigned to one of two groups, intervention program
      (supervises exercise program) and control group (community based exercise)
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2005</start_date>
  <completion_date type="Actual">January 2008</completion_date>
  <primary_completion_date type="Actual">January 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Natriuretic Brain Pro-peptid</measure>
    <time_frame>8 weeks</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>oxygen consumption</measure>
    <time_frame>8 weeks</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">49</enrollment>
  <condition>Chronic Heart Failure</condition>
  <arm_group>
    <arm_group_label>controlled, supervised exercise protocol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>controlled, supervised exercise protocol within a cardiac rehabilitation program</description>
  </arm_group>
  <arm_group>
    <arm_group_label>community based exercise</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>educational program and not supervises exercise program</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>controlled, supervised exercise protocol</intervention_name>
    <description>exercise program  within a cardiac rehabilitation program</description>
    <arm_group_label>controlled, supervised exercise protocol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients older than 18 years, diagnosed with heart failure (NYHA) II-IV for more than
             six months

        Exclusion Criteria:

          -  patients with NYHA functional class I, who had attended a cardiac rehabilitation
             program previously, patients with decompensated diabetes mellitus, hypertension
             difficult to control, ischemic heart disease in the last month, prior pulmonary
             embolism, chronic obstructive pulmonary disease, restrictive lung disease , aortic
             stenosis, new episode of atrial fibrillation and musculoskeletal diseases that limit
             the performance of physical activity
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jesus Alberto Plata Contreras, physiatrist</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rehabilitation in health research group. Universidad de Antioquia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ana Milena García Montoya, Resident</last_name>
    <role>Study Chair</role>
    <affiliation>Universidad de Antioquia,Rehabilitation in health research group</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sigifredo Ospina, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario San Vicente Fundación</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Luz Helena Lugo Agudelo, physiatrist</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidad de Antioquia, Rehabilitation in health research group</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universidad de Antioquia</name>
      <address>
        <city>Medellín</city>
        <state>Antioquia</state>
        <zip>050010</zip>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Colombia</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 14, 2014</lastchanged_date>
  <firstreceived_date>March 12, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Grupo Rehabilitacion en Salud</investigator_affiliation>
    <investigator_full_name>Jesus Alberto Plata Contreras</investigator_full_name>
    <investigator_title>M.D Epidemiologist</investigator_title>
  </responsible_party>
  <keyword>chronic heart failure</keyword>
  <keyword>cardiac rehabilitation</keyword>
  <keyword>exercise</keyword>
  <keyword>Natriuretic Brain Pro-peptid</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
